Hong Kong stocks surged, Shiyao Group (01093.HK) rose more than 4%, Chairman Cai Dongchen increased holdings, and SYH2085 was approved for clinical trials in China.

According to the Securities Times app, China Pharmaceutical Group (01093.HK) has risen by over 4%, as of the time of writing, up 4.12% to HK$8.59, with a trading volume of HK$443 million.